Immunology and Microbiology
Vaccination Policy
100%
Adoptive Immunity
93%
Cytotoxic T-Cell
93%
Omicron Coronavirus Variant
93%
Severe Acute Respiratory Syndrome Coronavirus 2
83%
T Cell
78%
Vaccine Efficacy
61%
COVID-19
46%
Myeloid
46%
Immunodeficiency
43%
Antigen Specificity
19%
Adaptive Immune System
14%
Epitope
14%
Memory T Cell
13%
Immune Response
13%
Antibody Titer
7%
T Cell Activation
6%
CD4 CD8 Ratio
6%
Stem Cell
6%
Cell Composition
6%
Booster Dose
6%
Immunodominance
6%
Spike
6%
HLA A24 Antigen
6%
Antibody Response
6%
Cell Specificity
6%
Keyphrases
Immunocompromised State
93%
SARS-CoV-2 mRNA Vaccination
70%
T Cell Response
46%
Anamnestic
46%
BNT162b2
46%
COVID-19 mRNA Vaccine
46%
CD8+ T Cells
46%
Immunodeficiency
35%
Booster Vaccination
23%
Cytotoxic Profile
23%
Autoreactive T Cells
23%
BNT162b2 Vaccine
15%
T Cell Persistence
15%
CD-8
11%
Proliferative Activity
11%
Cell-like
11%
Adaptive Immunity
11%
Healthy Controls
11%
Severe Disease
11%
COVID-19
11%
Resilient Response
11%
Omicron Infection
11%
Infected Individual
11%
Antibody Evasion
11%
Poor Responders
11%
Cell Composition
11%
Omicron Sub-lineages
11%
Stem Cell-like Properties
11%
Wuhan
11%
Immune Response
11%
Vaccine Dose
11%
Immunodeficient
11%
T Cells
11%